Synergistic Opioid Overdose Prevention and Response System
Legal Citation
Summary of the Inventive Concept
A comprehensive system integrating implantable drug delivery devices with AI, IoT, and blockchain technologies to prevent and respond to opioid overdoses, providing real-time monitoring, personalized interventions, and secure data management.
Background and Problem Solved
The original patent for a drug delivery device and method addressed the need for effective opioid overdose treatment. However, it did not provide a comprehensive solution for prevention, real-time detection, and secure data management. The new inventive concept solves this problem by integrating the implantable drug delivery device with distinct technologies to create a powerful system for opioid overdose prevention and response.
Detailed Description of the Inventive Concept
The synergistic system comprises an implantable drug delivery device, a wearable IoT sensor detecting physiological changes indicative of an overdose, and a blockchain-based platform for secure data storage and sharing of overdose event information. The system can also integrate an AI-powered health analytics platform to predict overdose risk and optimize drug release based on individual patient profiles. Additionally, a mobile app utilizing machine learning algorithms can identify high-risk individuals, and a network of emergency responders can be alerted via blockchain-based communication. The system enables real-time opioid overdose detection, personalized interventions, and secure data management.
Novelty and Inventive Step
The new claims introduce the novel concept of integrating the implantable drug delivery device with AI, IoT, and blockchain technologies to create a comprehensive system for opioid overdose prevention and response. This integration is non-obvious and provides a synergistic effect, enabling real-time monitoring, personalized interventions, and secure data management.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include using different types of sensors, such as ECG or blood glucose sensors, or integrating with other health analytics platforms. The system could also be adapted for use in different settings, such as hospitals or clinics, or for use with different types of drugs.
Potential Commercial Applications and Market
The synergistic opioid overdose prevention and response system has significant commercial potential in the healthcare industry, particularly in the areas of addiction treatment and emergency response. The system could be marketed to healthcare providers, insurance companies, and government agencies, and could potentially reduce healthcare costs and improve patient outcomes.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/14276 |
| A | A61 | A61B5/4839 |
| A | A61 | A61B5/4845 |
| A | A61 | A61B5/4848 |
| A | A61 | A61K9/0024 |
| A | A61 | A61K9/0097 |
| A | A61 | A61M5/44 |
| A | A61 | A61M31/002 |
| A | A61 | A61M37/0069 |
| A | A61 | A61B5/01 |
| A | A61 | A61F2250/0068 |
| A | A61 | A61K31/485 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Technology, Specifically Drug Delivery Systems and Physiological Monitoring, with expertise in implantable devices, sensor technologies, and pharmaceutical intervention systems
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in biomedical engineering, electrical engineering, or bioengineering, possessing knowledge of medical device design, sensor integration, data analytics, and pharmaceutical delivery mechanisms
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with implantable drug delivery devices represents a natural technological progression, where IoT sensors, AI analytics, and blockchain platforms provide predictable enhancements to existing medical monitoring and intervention systems. The core drug delivery mechanism remains fundamentally consistent with the source patent, while the added technological layers represent incremental improvements using standard engineering techniques. The combination of known technologies to achieve a predictable result of enhanced medical monitoring and intervention would be considered obvious to a skilled practitioner in the field.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,758 |
|---|---|
| Title | Drug delivery device and method |
| Assignee(s) | Purdue Research Foundation |